Evaluation of the Odds of Survival of Patients with Micrometastasis of Lung Cancer to Rib

Document Type : Original Article (s)

10.22122/jims.v39i621.13515

Abstract

Background: Lung cancer is by far the leading cause of cancer-related death, and the most prevalent cancer worldwide. This study aimed to investigate the presence of micro metastasis in specimens obtained from rib resections after surgery, and its impact on the recurrence rate and prognosis of patients with early-stage lung cancer.
Methods: In this cross-sectional study, 49 patients with lung cancer underwent rib biopsy during lung resection surgery, and were referred to the pathology department for micrometastasis. In the next stage, all patients were followed up and their death or survival status was determined and the survival rate of patients according to the presence or absence of rib micrometastasis was evaluated and compared.
Findings: Of the 49 studied patients, 10 (20.4%) had lung to rib micrometastasis. The mean survival time in patients with and without rib micrometastasis was 10.80 ± 1.75 and 26.58 ± 3.58 months, respectively, and the mean survival in the group with rib micrometastasis was significantly lower (P = 0.011).
Conclusion: It seems that the presence of rib micrometastasis in patients with lung cancer is associated with a reduced survival time. Therefore, bone biopsy of patients with lung cancer in the time of thoracotomy to determine rib micrometastasis, may be helpful in timely treatment and increase patient survival.

Keywords

References

Yang D, Liu Y, Bai C, Wang X, Powell CA. Epidemiology of lung cancer and lung cancer screening programs in China and the United States. Cancer Lett 2020; 468: 82-7.
Dela Cruz CS, Tanoue LT, Matthay RA. Lung cancer: Epidemiology, etiology, and prevention. Clin Chest Med 2011; 32(4): 605-44.
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61(2): 69-90.
Mohajeri G, Mohajeri MR, Afshar-Moghaddam N, Aslanpour A. The significance of clinicopathological aspects of tumor for the detection of liver micrometastasis in patients with colorectal cancer. J Res Med Sci 2014; 19(5): 410-3.
de Alencar VTL, Formiga MN, de Lima VCC. Inherited lung cancer: A review. Ecancermedicalscience 2020; 14: 1008.
Lightdale CJ. Esophageal cancer. Am J Gastroenterol 1999; 94(1): 20-9.
Rankin NM, McWilliams A, Marshall HM. Lung cancer screening implementation: Complexities and priorities. Respirology 2020; 25(Suppl 2): 5-23.
Fujibayashi Y, Ogawa H, Kitazume M, Nishikubo M, Nishioka Y, Kimura K, et al. Pleural invasion, epidermal growth factor receptor mutation and carcinoembryonic antigen level affect pleural lavage cytology-positive status in non-small-cell lung cancer. Eur J Cardiothorac Surg 2021; 59(4): 791-8.
Pantel K, Izbicki J, Passlick B, Angstwurm M, Haussinger K, Thetter O, et al. Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases. Lancet 1996; 347(9002): 649-53.
Passlick B, Kubuschok B, Izbicki JR, Thetter O, Pantel K. Isolated tumor cells in bone marrow predict reduced survival in node-negative non-small cell lung cancer. Ann Thorac Surg 1999; 68(6): 2053-8.
O'sullivan GC, Sheehan D, Clarke A, Stuart R, Kelly J, Kiely MD, et al. Micrometastases in esophagogastric cancer: High detection rate in resected rib segments. Gastroenterology 1999; 116(3): 543-8.
Cote RJ, Hawes D, Chaiwun B, Beattie EJ. Detection of occult metastases in lung carcinomas: progress and implications for lung cancer staging. J Surg Oncol 1998; 69(4): 265-74.
Pantel K, Schlimok G, Angstwurm M, Weckermann D, Schmaus W, Gath H, et al. Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow. J Hematother 1994; 3(3): 165-73.
Mohajeri G, Sanei MH, Tabatabaee SA, Hashemi SM, Amjad E, Mohajeri MR, et al. Micrometastasis in non-small-cell lung cancer: Detection and staging. Ann Thorac Med 2012; 7(3): 149-52.
Ryan P, Furlong H, Murphy CG, O'Sullivan F, Walsh TN, Shanahan F, et al. Prognostic significance of prospectively detected bone marrow micrometastases in esophagogastric cancer: 10-year follow-up confirms prognostic significance. Cancer Med 2015; 4(8): 1281-8.
Izbicki JR, Hosch SB, Pichlmeier U, Rehders A, Busch C, Niendorf A, et al. Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. N Engl J Med 1997; 337(17): 1188-94.
Mattioli S, D'Ovidio F, Tazzari P, Pilotti V, Daddi N, Bandini G, et al. Iliac crest biopsy versus rib segment resection for the detection of bone marrow isolated tumor cells from lung and esophageal cancer. Eur J Cardiothorac Surg 2001; 19(5): 576-9.
Bayazidi Y, Homaie Rad E. Comparison of quality of life in patients with bone metastasis under treatment with single fraction and multiple fraction radiotherapy methods in Shiraz during 2012. Razi J Med Sci 2015; 21(128): 28-36. [In Persian].
Kakhki VR, Anvari K, Sadeghi R, Mahmoudian AS, Torabian-Kakhki M. Pattern and distribution of bone metastases in common malignant tumors. Nucl Med Rev Cent East Eur 2013; 16(2): 66-9.
Ruffato A, Mattioli S, Pileri S, Daddi N, D'Ovidio F, Pilotti V, et al. Do bone marrow isolated tumor cells influence long-term survival of non-small cell lung cancer? Eur J Cardiothorac Surg 2009; 35(3): 463-8.
Journal of Isfahan Medical School
Volume 39, Issue 621
2021
Pages 262-269

Files

History

  • Receive Date: 01 April 2022
  • Accept Date: 01 April 2022

Share

How to cite

Statistics